Cardiovascular ‘polypill’ improved medication adherence, hypertension
Major finding: Rates of adherence to CVD medications were 86.3% for both polypill groups, compared with 64.7% for the control group.
Data source: An international open-label, randomized clinical trial involving 2,004 high-risk CVD patients followed for 12-24 months.
Disclosures: UMPIRE was funded by the European Commission and Dr. Reddy's Laboratories. Dr. Thom reported no financial conflicts of interest; his associates reported numerous ties to industry sources.
FROM JAMA
The European Commission and Dr. Reddy’s Laboratories funded the UMPIRE study. Dr. Thom reported no financial conflicts of interest; his associates reported numerous ties to industry sources.
To earn 0.25 hours AMA PRA Category 1 credit after reading this article, take the post-test here.
